Disease background

LEMS is a rare neuromuscular autoimmune disease characterised by progressive muscle weakness, hyporeflexia/areflexia and autonomic dysfunction. Approximately half of all cases are associated with malignancy.2,3

Treatment variability

Treating LEMS can be unpredictable due to variability in compounded medications and differing patient phenotypes.4,5


Predictability you can rely on to help deliver the results your LEMS patients need.

1.  FIRDAPSE® Summary of Product Characteristics 2017.  2.  Titulaer MJ, Lang B, Verschuuren JJGM. Lancet Neurol 2011;10:1098‒1107.  3.  Seneviratne U and de Silva R. Postgrad Med J 1999;75:516‒520.  4.  Green DM, Jones AC, Brain KR. J Clin Pharm Ther 2012;37(1):53‒57.  5.  Haroldsen PE et al. Pharma Res Per 2015;3:e00099.